NCT05347030 is a NA clinical trial of Acupuncture in Impaired Glucose Tolerance, sponsored by Yan Yan.

Who is sponsoring NCT05347030?

NCT05347030 is sponsored by Yan Yan.

What drugs are being tested in NCT05347030?

Interventions in NCT05347030: Acupuncture, Sham Acupuncture.

What condition does NCT05347030 study?

NCT05347030 studies Impaired Glucose Tolerance, Overweight, Obese, Prediabetic State.

Is NCT05347030 still recruiting?

NCT05347030 is currently status unknown. Last updated 23 February 2023.

Last reviewed 2023-02-23 · How we verify

NCT05347030

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population

Status unknown NA Last updated 23 February 2023

What this trial tests

NA trial testing Acupuncture in Impaired Glucose Tolerance in 196 participants. Status unknown.

Timeline

6 October 2022

Primary endpoint
1 July 2024

31 December 2024

Quick facts

Lead sponsor	Yan Yan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	196
Start date	6 October 2022
Primary completion	1 July 2024
Estimated completion	31 December 2024
Sites	1 location across China

Drugs / interventions tested

Acupuncture — full drug profile →
Sham Acupuncture

Conditions studied

Impaired Glucose Tolerance — all drugs for Impaired Glucose Tolerance →
Overweight — all drugs for Overweight →
Obese — all drugs for Obese →
Prediabetic State — all drugs for Prediabetic State →

Sponsor

Yan Yan

Who can join

Adults 18 to 60, any sex, with Impaired Glucose Tolerance or Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, multicenter, parallel-group, participants- and assessors-blinded randomized trial aiming to evaluate the effectiveness and safety of acupuncture in improving glucose metabolism for overweight/obese Participants with IGT, in comparison with sham acupuncture.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Acupuncture for Impaired Glucose Tolerance in People With Obesity: A Protocol for a Multicenter Randomized Controlled Trial.
Yan Y, Sun Y, Wang X, Zhu L, et al · · 2022 · cited 1× · PMID 35903320 · DOI 10.3389/fmed.2022.932102

Verify or expand the search:

Other trials of Acupuncture

Trials testing the same drug.

NCT07522567 — Efficacy of Acupuncture on Chronic Tinnitus and Its Association With Auditory Brainstem Response Measures · NA · not yet recruiting
NCT07575334 — Acupuncture Therapy for Sudden Sensorineural Hearing Loss · NA · recruiting
NCT07522710 — Clinical Study on Intensive Multi-acupuncture in the Treatment of Neck and Shoulder Myofascial Pain Syndrome · NA · not yet recruiting
NCT07505927 — Acupuncture for Postoperative Gastric Emptying Delay · NA · not yet recruiting
NCT07410793 — Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis. · Phase 2 · recruiting

Other recruiting trials for Impaired Glucose Tolerance

Currently open trials in the same condition.

NCT06964620 — Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diab · EARLY_PHASE1 · recruiting
NCT06507722 — Night Owl Metabolism · NA · recruiting
NCT05912348 — The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults · NA · recruiting
NCT05873322 — Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents Wi · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05347030 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yan Yan
Last refreshed: 23 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05347030.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing